GNE-6776 is a selective USP7 inhibitor that non-covalently targets USP7 (IC50 value at 1.34 µM) to attenuate ubiquitin binding, thus inhibiting deubiquitinase activity. It induces tumour cell death and enhances cytotoxicity with chemotherapeutic agents a